Description
NITRIC OXIDE THERAPY
First action · last action
2019-10-01 · 2019-10-01
Transactions
1
First transaction's obligation
$79,596
Base + all options value (sum of deltas)
$79,596
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D60737
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$79,596= $79,596
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$79,596 | $79,596 | NITRIC OXIDE THERAPY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI XXQHL619FUN6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226F0380 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $9,966 | FY2026 |
| 36C24226N0305 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $360 | FY2026 |
| 36C26226F0170 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · J065 · MAINT/REPAIR/REBUILD OF EQUIPMENT- MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES | $10,794 | FY2026 |
| 36C26226P0517 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q999 · MEDICAL- OTHER | $71,960 | FY2026 |
| 36C24126N0303 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6835 · MEDICAL GASES | $21,706 | FY2026 |
| 36C25926P0226 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $10,794 | FY2026 |
Other recipients under Q501 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726N0137 | TITAN-AUXO, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $3,326,721 | FY2026 |
| 36C24721P1101 | GENERAL ELECTRIC COMPANY | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $10,997 | FY2021 |
| 36C24720P0438 | RAS ENTERPRISES LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $1,067,533 | FY2020 |
| 36C24718F0001 | MALLINCKRODT LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $40,222 | FY2018 |
| VA24717C0045 | LINDE GAS & EQUIPMENT INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $164,394 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24720F0001_3600_V797D60737_3600 · retrieved 2026-09-26.